其它目标|Other Targets-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

其它目标

Khasianine (2S,3R,4R,5R,6S)-2-(((2R,3S,4R,5R,6R)-4,5-二羟基-2-(羟甲基)-6-(((4S,5'R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,4,5,6,6a,6b,7,8,8a,8b,9,11a,12,12a,12b-十六氢螺[萘并[2',1':4,5]茚并[2,1-b]呋喃-10,2'-哌啶]-4-基)氧基)四氢-2H-吡喃-3-基)氧基)-6-甲基四氢-2H-吡喃-3,4,5-三醇: BJS997769332449-98-298%; ￥5676.0050mg

N-(3-Iodophenyl)-6,7-dimethoxyquinazolin-4-amine N-(3-碘苯基)-6,7-二甲氧基喹唑啉-4-胺: BJS8636273189290-58-299%; ￥1636.0050mg

Ala-ser-thr-thr-thr-asn-tyr-thracetate L-丙氨酰-L-丝氨酰-L-苏氨酰-L-苏氨酰-L-苏氨酰-L-天冬氨酰-L-酪氨酰-L-苏氨酸: BJS5537283106362-32-798%; ￥2825.0050mg

L-Histidine hydrochloride hydrate L-组氨酸盐酸盐水合物: BJS31235075934-29-298%; ￥76.0025g

(2S,3S,4S,5R,6S)-6-((5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (2S,3S,4S,5R,6S)-6-((5,7-二羟基-2-(4-羟基苯基)-4-氧代-4H-苯并吡喃-3-基)氧基)-3,4,5-三羟基四氢-2H-吡喃-2-甲酸: BJS749900022688-78-498%; ￥3318.005mg

Autocamtide-2-related inhibitory peptide, myristoylated (2S,5S,8S,11S,14S,17S)-17-((2S,5S,8S,11S,14S,17S,20S)-20-氨基-2-(3-氨基-3-氧代丙基)-17-(4-氨基丁基)-5,8-双(3-胍基丙基)-11-异丁基-14-甲基-4,7,10,13,16,19,26-七氧代-3,6,9,12,15,18,25-七氮杂三十九烷酰胺基)-8-(羧甲基)-2-异丁基-11-异丙基-5,14-二甲基-4,7,10,13,16-五氧杂-3,6,9,12,15-五氮杂二十烷二酸: BJS5393493201422-04-099%; ￥2098.005mg

N-(2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)ethyl)-2-bromoacetamide N-(2-(2-(2-(2-叠氮乙氧基)乙氧基)乙氧基)乙基)-2-溴乙酰胺: BJS4304992940005-81-298%; ￥1709.00100mg

20-Azido-3,6,9,12,15,18-hexaoxaicosan-1-ol 20-叠氮基-3,6,9,12,15,18-六氧杂二十烷-1-醇: BJS98817801274892-60-297%; ￥4200.001g

Methyl 2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)acetate 2-(2-(2-(2-叠氮乙氧基)乙氧基)乙氧基)乙酸甲酯: BJS70521901253389-31-998%; ￥9030.001g

(E)-1-(3-((E)-3,7-Dimethylocta-2,6-dien-1-yl)-2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one (E)-1-(3-((E)-3,7-二甲基辛-2,6-二烯-1-基)-2,4-二羟基苯基)-3-(4-羟基苯基)丙-2-烯-1-酮: BJS891764562949-76-299%; ￥6852.0025mg

3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-7H-[1,4]dioxino[2,3-g]chromen-7-one 3-(4-羟基-3,5-二甲氧基苯基)-2-(羟甲基)-2,3-二氢-7H-[1,4]二氧环己烷并[2,3-g]苯并吡喃-7-酮: BJS4616267116521-73-498%; ￥5842.005mg

(3R,4S,4aS,9aR)-4a-Acetoxy-3-((1E,3E)-4-carboxypenta-1,3-dien-1-yl)-3-methyl-1-oxo-3,4,4a,5,6,9-hexahydro-1H-4,9a-ethanocyclohepta[c]pyran-7-carboxylic acid (3R,4S,4aS,9aR)-4a-乙酰氧基-3-((1E,3E)-4-羧基戊-1,3-二烯-1-基)-3-甲基-1-氧代-3,4,4a,5,6,9-六氢-1H-4,9a-乙桥环庚并[c]吡喃-7-羧酸: BJS768028182508-35-899%; ￥1823.005mg

(4S,5'R,6aR,6bS,8aS,8bS,9S,10R,11aS,12aS,12bR)-5',6a,8a,9-Tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,11a,12,12a,12b-octadecahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,8b(9H)-diol (4S,5'R,6aR,6bS,8aS,8bS,9S,10R,11aS,12aS,12bR)-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,11a,12,12a,12b-十八氢螺[萘并[2',1':4,5]茚并[2,1-b]呋喃-10,2'-吡喃]-4,8b(9H)-二醇: BJS4663442507-89-199%; ￥8190.0010mg

(R)-4-((3R,5R,8R,9S,10S,12R,13R,14S,17R)-3,12-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (R)-4-((3R,5R,8R,9S,10S,12R,13R,14S,17R)-3,12-二羟基-10,13-二甲基十六氢-1H-环戊二烯并[a]菲-17-基)戊酸: BJS8177135570-62-799%; ￥1447.001mg

17-Epidihydroimperialine (3S,4aS,5R,6aS,6bS,8aS,9S,9aS,12S,15aS,15bR,16aS,16bR)-9,12,16b-三甲基二十四氢苯并[4,5]茚并[1,2-h]吡啶并[1,2-b]异喹啉-3,5,9-三醇: BJS499571223496-43-798%; ￥2915.005mg

N5-((R)-2-(Allylthio)-1-carboxyethyl)-L-glutamine N5-((R)-2-(烯丙硫基)-1-羧基乙基)-L-谷氨酰胺: BJS945422391216-95-498%; ￥7615.0025mg

13,21-Dihydroeurycomanone (1R,2R,3S,3aR,3a1R,4R,6aR,7aS,11S,11aS,11bR)-1,2,3a,4,11-五羟基-3,8,11a-三甲基-1,2,3,3a,4,7,7a,11,11a,11b-十氢-5H-1,3a1-(环氧甲桥)二苯并[de,g]苯并吡喃-5,10(6aH)-二酮: BJS1486151129587-06-098%; ￥8524.0010mg

(S)-1-((3R,6S,9S,12S,15S)-6-(2-Amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-((S)-sec-butyl)-15-(4-methoxybenzyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacycloicosane-3-carbonyl)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide xacetate (S)-1-(((3R,6S,9S,12S,15S)-6-(2-氨基-2-氧代乙基)-9-(3-氨基-3-氧代丙基)-12-((S)-仲丁基)-15-(4-甲氧基苄基)-5,8,11,14,17-五氧代-1-硫杂-4,7,10,13,16-五氮杂环二十烷-3-羰基)-N-((S)-1-(((2-氨基-2-氧代乙基)氨基)-4-甲基-1-氧代戊-2-基)吡咯烷-2-甲酰胺 x乙酸盐: BJS29808551631754-28-398%; ￥10223.00250mg

RUVBL1/2 ATPase-IN-1 (5,7-二甲基-6-(4-甲基苄基)吡唑并[1,5-a]嘧啶-3-基)(4-(3-(三氟甲基)苯基)哌嗪-1-基)甲酮: BJS3081721423128-55-699%; ￥4694.0025mg

CCR8 antagonist 1 4-((4-(2-甲基苯甲酰胺基)萘)-1-磺酰胺基)哌啶-1-甲酸乙酯: BJS1488635723304-76-598%; ￥4570.0050mg

1 2 3 4 5 6 7 8 9 ... 377